BioCentury
ARTICLE | Financial News

V-Bio closes EUR 76M fund

December 2, 2016 12:30 AM UTC

V-Bio Ventures closed its first life sciences fund at EUR 76 million ($81 million). LPs include the European Investment Fund (EIF), PMV-ARKimedes, Korys, KU Leuven, Gimv, SFPI-FPIM, BNP Paribas Fortis Private Equity and Ghent University.

V-Bio Ventures Fund 1 is designed to fund 15-18 early stage companies developing therapeutics, diagnostics and agricultural products. ...

BCIQ Company Profiles

Confo Therapeutics N.V.